# Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes

> **NCT02618577** · PHASE3 · TERMINATED · sponsor: **Atrial Fibrillation Network** · enrollment: 2608 (actual)

## Conditions studied

- Atrial High Rate Episodes

## Interventions

- **DRUG:** Edoxaban
- **DRUG:** ASA

## Key facts

- **NCT ID:** NCT02618577
- **Lead sponsor:** Atrial Fibrillation Network
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 2608 (ACTUAL)
- **Why stopped:** following a recommendation from the data safety and monitoring board due to safety concerns and a tendency towards futility.
- **Last updated:** 2025-02-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02618577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02618577, "Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02618577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*